UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

BJOG : an international journal of obstetrics and gynaecology, 2022-02, Vol.129 (3), p.412-420

2022

Volltextzugriff (PDF)

Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations

American journal of obstetrics and gynecology, 1998-02, Vol.178 (2), p.203-211

1998

Volltextzugriff (PDF)

28: Chronic cervicitis: presenting features and responses to therapy

American journal of obstetrics and gynecology, 2015-12, Vol.213 (6), p.907-907

2015

Volltextzugriff (PDF)

17: Efficacy and safety of oral VT-11611 in a randomized phase 2a study in patients with acute vulvovaginal candidiasis: six-month follow-up

American journal of obstetrics and gynecology, 2015-12, Vol.213 (6), p.890-890

2015

Volltextzugriff (PDF)

18: NDV-3A vaccine reduces the frequency of vaginitis in patients with recurrent vulvovaginal candidiasis

American journal of obstetrics and gynecology, 2016-12, Vol.215 (6), p.S822-S822

2016

Volltextzugriff (PDF)

Tinidazole Therapy for Metronidazole-Resistant Vaginal Trichomoniasis

Clinical infectious diseases, 2001-10, Vol.33 (8), p.1341-1346

2001

Volltextzugriff (PDF)

6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis

American journal of obstetrics and gynecology, 2015-12, Vol.213 (6), p.885-885

2015

Volltextzugriff (PDF)

15: To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

American journal of obstetrics and gynecology, 2016-12, Vol.215 (6), p.S821-S821

2016

Volltextzugriff (PDF)

17: Comparative analysis of ESwab™ and standard collection systems for nugent scoring in the diagnosis of bacterial vaginosis

American journal of obstetrics and gynecology, 2015-12, Vol.213 (6), p.902-903

2015

Volltextzugriff (PDF)

Chronic vulvovaginal candidiasis

American family physician, 2001-02, Vol.63 (4), p.697-702

Nyirjesy, P

2001

Volltextzugriff (PDF)

Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical Implications

Antimicrobial Agents and Chemotherapy, 2003-01, Vol.47 (1), p.34-38

2003

Volltextzugriff (PDF)

Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole

American journal of obstetrics and gynecology, 2001-08, Vol.185 (2), p.363-369

2001

Volltextzugriff (PDF)

Fluconazole resistant candida albicans vaginal infections at a referral center and results with boric acid as a treatment regimen

American journal of obstetrics and gynecology, 2023-02, Vol.228 (2), p.S783-S783

2023

Volltextzugriff (PDF)

P305 Mycoses génitales (MG) sous canaglifozine chez des patients diabétiques de type 2

Diabetes & metabolism, 2014-03, Vol.40, p.A99-A100

2014

Volltextzugriff (PDF)

Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study

Sexually transmitted infections, 2001-02, Vol.77 (1), p.53-57

2001

Volltextzugriff (PDF)

Metronidazole-resistant trichomoniasis: beneficial pharmacodynamic relationship with high-dose oral tinidazole and vaginal paromomycin combination therapy

American journal of obstetrics and gynecology, 2018-12, Vol.219 (6), p.645-646

2018

Volltextzugriff (PDF)

Oteseconazole for RVVC in diabetes: post-hoc analysis of safety and clinical response in phase 3 studies

American journal of obstetrics and gynecology, 2023-02, Vol.228 (2), p.S784-S784

2023

Volltextzugriff (PDF)

A post hoc analysis of secnidazole 2 g for the treatment of bacterial vaginosis: effect of 2016 FDA guidance on clinical response rates in a subpopulation of patients

American journal of obstetrics and gynecology, 2017-12, Vol.217 (6), p.739-739

2017

Volltextzugriff (PDF)

Re: A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect

BJOG : an international journal of obstetrics and gynaecology, 2019-06, Vol.126 (7), p.945-946

2019

Volltextzugriff (PDF)

Results from RADIANT, a phase 2, randomized, open-label, sponsor-blinded study of CD101 topical in patients with moderate-to-severe acute vulvovaginal candidiasis

American journal of obstetrics and gynecology, 2017-12, Vol.217 (6), p.715-715

2017

Volltextzugriff (PDF)

Long term outcomes of women with recurrent vulvovaginal candidiasis after a course of maintenance fluconazole

American journal of obstetrics and gynecology, 2017-12, Vol.217 (6), p.743-743

2017

Volltextzugriff (PDF)

Metronidazole-Resistant Vaginal Trichomoniasis — An Emerging Problem

The New England journal of medicine, 1999-07, Vol.341 (4), p.292-293

1999

Volltextzugriff (PDF)

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: aglobal phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

BJOG : an international journal of obstetrics and gynaecology, 2022-02, Vol.129 (3), p.412-420

2022

Volltextzugriff (PDF)

Results from a phase 2, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of VT 1161 oral tablets in the treatment of patients with recurrent vulvovaginal candidiasis

American journal of obstetrics and gynecology, 2017-12, Vol.217 (6), p.715-715

2017

Volltextzugriff (PDF)

VAGINITIS IN THE ADOLESCENT PATIENT

The Pediatric clinics of North America, 1999-08, Vol.46 (4), p.733-745

Nyirjesy, Paul

1999

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(89)
Berichte
(1)

Sprache

Englisch
(89)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(44)
Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Female
(41)
Biological And Medical Sciences
(28)
Medical Sciences
(25)
Obstetrics & Gynecology
(25)
Adult
(17)
Middle Aged
(16)
Infectious Diseases
(15)
Gynecology. Andrology. Obstetrics
(12)
Candidiasis, Vulvovaginal - Drug Therapy
(8)
Aged
(7)
Chronic Disease
(7)
Microbiology
(7)
Treatment Outcome
(7)
Vaginitis
(7)
Antifungal Agents - Therapeutic Use
(6)
Immunology
(6)
Obstetrics And Gynecology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations

28: Chronic cervicitis: presenting features and responses to therapy

17: Efficacy and safety of oral VT-11611 in a randomized phase 2a study in patients with acute vulvovaginal candidiasis: six-month follow-up

18: NDV-3A vaccine reduces the frequency of vaginitis in patients with recurrent vulvovaginal candidiasis

Tinidazole Therapy for Metronidazole-Resistant Vaginal Trichomoniasis

6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis

15: To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

17: Comparative analysis of ESwab™ and standard collection systems for nugent scoring in the diagnosis of bacterial vaginosis

Chronic vulvovaginal candidiasis

Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical Implications

Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole

Fluconazole resistant candida albicans vaginal infections at a referral center and results with boric acid as a treatment regimen

P305 Mycoses génitales (MG) sous canaglifozine chez des patients diabétiques de type 2

Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study

Metronidazole-resistant trichomoniasis: beneficial pharmacodynamic relationship with high-dose oral tinidazole and vaginal paromomycin combination therapy

Oteseconazole for RVVC in diabetes: post-hoc analysis of safety and clinical response in phase 3 studies

A post hoc analysis of secnidazole 2 g for the treatment of bacterial vaginosis: effect of 2016 FDA guidance on clinical response rates in a subpopulation of patients

Re: A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect

Results from RADIANT, a phase 2, randomized, open-label, sponsor-blinded study of CD101 topical in patients with moderate-to-severe acute vulvovaginal candidiasis

Long term outcomes of women with recurrent vulvovaginal candidiasis after a course of maintenance fluconazole

Metronidazole-Resistant Vaginal Trichomoniasis — An Emerging Problem

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: aglobal phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

Results from a phase 2, randomized, double-blind, placebo-controlled, dose ranging study to evaluate the efficacy and safety of VT 1161 oral tablets in the treatment of patients with recurrent vulvovaginal candidiasis

VAGINITIS IN THE ADOLESCENT PATIENT

Suchergebnisse filtern